Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10328074 Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors

Patent 10328074 was granted and assigned to Boehringer Ingelheim on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Patent abstract

Method for treating AML and MM by administration of a compound of the formula (I)

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10328074 Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo